• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

JG-98

CAS No. 1456551-16-8

JG-98 ( JG98 )

产品货号. M11970 CAS No. 1456551-16-8

JG-98 是一种变构 Hsp70 抑制剂,对乳腺癌细胞系 MDA-MB-231 和 MCF-7 的活性和稳定性比 MKT-077 高 3 倍以上(EC50 分别为 0.4 uM 和 0.7 uM)。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
2MG ¥1199 有现货
5MG ¥2130 有现货
10MG ¥3426 有现货
25MG ¥5565 有现货
50MG ¥7938 有现货
100MG ¥10773 有现货
200MG 获取报价 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    JG-98
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    JG-98 是一种变构 Hsp70 抑制剂,对乳腺癌细胞系 MDA-MB-231 和 MCF-7 的活性和稳定性比 MKT-077 高 3 倍以上(EC50 分别为 0.4 uM 和 0.7 uM)。
  • 产品描述
    JG-98 is an allosteric Hsp70 inhibitor, displays >3-fold more active, greater stability than MKT-077 against the breast cancer cell lines MDA-MB-231 and MCF-7 (EC50 of 0.4 uM and 0.7 uM, respectively); strongly affects autophagic flux, increases p62 oligomerization and reduces p62 monomer; destabilizes FoxM1 and relieved suppression of downstream effectors, including p21 and p27.
  • 体外实验
    JG-98 (30 nM-30 μM; 72 hours) has antiproliferative activity across a range of cell lines with the EC50s between ~0.3 and 4 μM.JG-98 (10 μM; 48 hours) activates apoptotic mediators (cleavage of caspase-3 and PARP) in MDA-MB-231 cells.JG-98 destabilizes FoxM1 and relieves suppression of downstream effectors, including p21 and p27. Cell Proliferation Assay Cell Line:MCF-7, MDA-MB-231, A375, MeWo, HeLa, HT-29, SKOV3, Jurkat, mouse embryonic fibroblasts (MEF), MM1.R, INA6, RPMI-8226, JJN-3, U266, NCI-H929, L363, MM1.S, KMS11, LP-1, AMO-1, OPM1, OPM2 cells Concentration:30 nM-30 μM Incubation Time:72 hours Result:Active against all of the lines tested, and the EC50s were variable (between ~0.3 μM and 4 μM). Normal MEFs and OPM1 and OPM2 were relatively less sensitive.Western Blot Analysis Cell Line:MDA-MB-231 cells Concentration:10 μM Incubation Time:48 hours Result:Incudes apoptotic mediators cleavage of caspase 3 and PARP.
  • 体内实验
    JG-98 (3 mg/kg; i.p.; on days 0, 2, and 4) suppresses tumor growth in xenograft models bearing MCF7 and HeLa cells. Animal Model:6-week-old NCR mice (xenografts of MCF7 and HeLa cells) Dosage:3 mg/kg Administration:Intraperitoneal injection; on days 0, 2, and 4 Result:Limited tumor growth, but somewhat less effectively.
  • 同义词
    JG98
  • 通路
    Cytoskeleton/Cell Adhesion Molecules
  • 靶点
    HSP
  • 受体
    HSP70
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    1456551-16-8
  • 分子量
    534.532
  • 分子式
    C24H21Cl2N3OS3
  • 纯度
    >98% (HPLC)
  • 溶解度
    DMSO: Soluble ( < 1 mg/ml refers to the product slightly soluble or insoluble )
  • SMILES
    CCN1C(=CC2=[N+](C=CS2)CC3=CC=CC=C3)SC(=C4N(C5=C(S4)C=C(C=C5)Cl)C)C1=O.[Cl-]
  • 化学全称
    Thiazolium,2-[(Z)-[(5E)-5-(6-chloro-3-methyl-2(3H)-benzothiazolylidene)-3-ethyl-4-oxo-2-thiazolidinylidene]methyl]-3-(phenylmethyl)-,chloride (1:1)

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1. Li X. et al. ACS Med Chem Lett. 2013 Nov 14;4(11). 2. Li X, et al. Mol Cancer Ther. 2015 Mar;14(3):642-8.
产品手册
关联产品
  • SNX-0723

    SNX-0723 是一种选择性、脑渗透性、口服活性的 Hsp90 小分子抑制剂 (IC50=14 nM),可抑制 α-突触核蛋白寡聚化,EC50 为 48 nM。

  • Deoxyspergualin

    脱氧精胍菌素是抗肿瘤抗生素精胍菌素的衍生物,可与 Hsc70 特异性结合。

  • TRC051384

    TRC051384 是热休克蛋白 Hsp70 的诱导剂,可激活热休克因子 1 并增强神经元和神经胶质细胞中的 Hsp72 表达。